📰 Guidelines Panel News
Page 8 - Guidelines Panel News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Guidelines Panel. Real-time updates on events, politics, business and more.
January 25, 2022
Florida Gov. Ron DeSantis says the state will "fight back" against the FDA's limitation of popular COVID-19 monoclonal antibody treatments.
January 25, 2022
Bamlanivimab plus etesevimab and REGEN-COV (casirivimab and imdevimab) are not authorized for use in any US states, territories, and jurisdictions due to the Omicron variant.
January 25, 2022
Florida Gov. Ron DeSantis says the state will "fight back" against the FDA's limitation of popular COVID-19 monoclonal antibody treatments.
January 25, 2022
Bamlanivimab plus etesevimab and REGEN-COV are not authorized for use in any US states, territories, and jurisdictions due to the Omicron variant.
January 24, 2022
/PRNewswire/ -- As we have throughout the COVID-19 pandemic, the U.S. Food and Drug Administration has used the best available science as the virus has evolved...
January 24, 2022
/PRNewswire/ -- As we have throughout the COVID-19 pandemic, the U.S. Food and Drug Administration has used the best available science as the virus has evolved...
January 22, 2022
ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero
January 22, 2022
Some patients seeking treatment outside hospitals can now use the antiviral remdesivir after U.S. drug regulators late Friday ...
January 19, 2022
Federal health agencies haven’t recognized ivermectin as an effective treatment for COVID-19 patients. According to Doctor Leland Stillman, the reason is more political than scientific, because otherwise there would be no bases for lockdowns or vaccine mandates.
January 14, 2022
The coronavirus pandemic has highlighted just how politicized medicine has become in the U.S. and around the world. From the way that the media stifled all discussions of hydroxychloroquine (HCQ) [...]